Clinical Trial 8497

Phoenix, AZ 85013


Study Summary:

Dedicated Phase I is conducting a clinical research trial testing an investigational product developed to enhance central nervous system remyelination in men and women with a diagnosis of relapsing, remitting or secondary progressive MS.


Qualified Participants Must:

• Be 18-60 years of age
• Have a diagnosis of MS
• Be willing to attend 8 overnight stays over a 22 week period


Qualified Participants May Receive:

All physical exams, laboratory tests and investigational product at NO charge and may be compensated up to $4,000 for time and travel.


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.